Danske Bank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Danske Bank's DGX Position: Q3 2026 in Review
Danske Bank increased its Quest Diagnostics (DGX) stake by 25% in Q3 2026, buying an estimated $3.91M and bringing the position to 85,461 shares worth $19.9M. The position accounts for 0.04% of the portfolio, ranked #321.
Danske Bank first reported a position in DGX in Q1 2024 and has held it in 11 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Danske Bank held 85,461 shares of Quest Diagnostics worth $19.9M as of Q3 2026.
- Danske Bank bought 16,900 Quest Diagnostics shares in Q3 2026, an estimated $3.91M.
- Quest Diagnostics made up 0.04% of Danske Bank's portfolio in Q3 2026, its #321 holding.
- Danske Bank first reported a position in Quest Diagnostics in Q1 2024 and has held it in 11 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.